Status:

COMPLETED

Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation

Lead Sponsor:

Hospital de Clinicas de Porto Alegre

Conditions:

Kidney Transplant; Complications

Immunosuppression

Eligibility:

All Genders

Brief Summary

The use of polyclonal anti-T cell antibodies (ATG) has benefits in kidney transplantation, however, its use is associated mainly with hematological, infectious, and neoplastic complications. Monitorin...

Detailed Description

Kidney transplantation is one of the major advances in medicine in the past 60 years. Currently, is considered the best treatment for terminal chronic kidney disease in the medium and long term, and t...

Eligibility Criteria

Inclusion

  • Kidney transplant patients from Hospital de Clínicas de Porto Alegre (HCPA) between October 2018 to March 2020 who received a single 3 mg/kg ATG dose at the immediate postoperative period. Recipients of standard and low immunological risk (PRA - panel reactive antibodies \<50% and without donor-specific antibodies), regardless of the time of cold ischemia and the presence of kidney failure in the donor.
  • Control group consisting of patients from the same and previous period, who received fractionated ATG dosing up to 6 mg/kg total dose.

Exclusion

  • Patients who used other induction strategies that did not include ATG in a single dose of 3 mg/kg or the fractionated dose of 6 mg/kg.
  • Patients who died within 24 hours after transplantation.
  • Patients who had a transplant nephrectomy within 24 hours after transplantation.
  • Pediatric recipients (\< 14 years old).
  • Recipients with incomplete data.

Key Trial Info

Start Date :

October 20 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 13 2021

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04835948

Start Date

October 20 2018

End Date

April 13 2021

Last Update

April 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil